AGIO 8-K 2026-01-12

AGIOS PHARMACEUTICALS, INC. (AGIO) 8-K dated 2026-01-12 — accession 0001439222-26-000018. This URL is the filing, not the AGIO hub.

AGIOS PHARMACEUTICALS, INC. (AGIO) is a biotechnology company listed on US.

AGIOS PHARMACEUTICALS, INC. filed a 8-K on 2026-01-12. Accession 0001439222-26-000018.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.

Not investment advice. The AGIO SEC hub lists recent forms. The stock page is the research view.